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Abstract
Purpose: Our study aimed to evaluate the technical success rate, interobserver
reproducibility, and accuracy of shearwave elastography (SWE) in the staging of hep-
atitis C virus (HCV)-associated liver fibrosis.
Methods: A total of 10 healthy controls and 49 patients with chronic liver disease were
enrolled prospectively. Two examiners performed point shearwave elastography (pSWE)
and two-dimensional shearwave elastography (2D-SWE) measurements with an RS85A
ultrasound scanner using the S-Shearwave application (Samsung Medison, Hongcheon,
Korea). The performance of S-Shearwave in the staging (METAVIR F0-F4) of liver
fibrosis was compared with prior transient elastography (TE) with receiver operating
characteristic (ROC) curve analysis.
Results: The interobserver reproducibility was excellentwith pSWE (ICC = 0.92, 95%CI:
0.86-0.95, P < .001). A very good agreement was found between pSWE and TE mea-
surements (ICC =0.85, 95% CI: 0.78-0.89, P < .001). The ROC analysis determined the
optimal cut-off values of pSWE for the staging of chronic hepatitis C-associated fibrosis
(F2, 1.46 m/s; F3, 1.63 m/s; F4, 1.95 m/s). Both observers achieved excellent diagnostic
accuracy (AUROC: 94% vs 97%) in the detection of significant (≥F2) liver fibrosis.
Conclusion: The interobserver agreement is excellent with S-Shearwave pSWE, and
observers can diagnose significant liver fibrosis with a comparable accuracy to TE.
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1 | INTRODUCTION
Fibrosis and architectural distortion is a common endpoint of chronic liver
disease (CLD) of various etiologies. Quantification of liver fibrosis is
essential for therapeutic decision-making in these patients. According to
current clinical practice guidelines, antiviral treatment is recommended
when significant grade fibrosis is detected. After the diagnosis of cirrhosis
has been established, regular screenings for complications and surveil-
lance for hepatocellular carcinoma (HCC) must be initiated.1 Traditionally,
liver biopsy has been considered the “gold standard” reference method
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for the diagnosis of liver fibrosis. However, low patient compliance,
prolonged procedure time, and the risk of complications are limiting its
use in large populations.2 Several noninvasive tests have been recently
developed to overcome the limitations of liver biopsies.
The shearwave elastography (SWE) techniques are designed to mea-
sure liver stiffness (LS), which has been established as a surrogate marker
of liver fibrosis.3 In many institutions, transient elastography (TE) has
become the standardmethod for noninvasivemeasurement of liver fibro-
sis. In recent guidelines on the treatment of HCV infection, noninvasive
elastography techniques are recommended for the initial assessment of
liver, with liver biopsy reserved for cases where there is uncertainty or
potential additional etiologies.4 Point shearwave elastography (pSWE)
and two-dimensional shearwave elastography (2D-SWE) combine SWE
with conventional B-mode sonograms.
Some studies have already demonstrated that reliability and diag-
nostic performance of SWE are identical and occasionally even supe-
rior to TE for the assessment of liver fibrosis.5 The S-Shearwave
elastography application has recently been made available on
Samsung ultrasound (US) scanners.6 In the present study, we have
assessed interobserver reproducibility of S-Shearwave measurements
in a group of healthy control subjects and patients with various grades
of liver fibrosis.
2 | PATIENTS AND METHODS
2.1 | Study population
The present study has been approved by the institutional ethics com-
mittee of our university, and written informed consent was obtained
from all subjects according to the Declaration of Helsinki. Between
October 2016 and June 2017, we prospectively enrolled 59 adult sub-
jects, which comprised two cohorts: a group of 10 healthy volunteers
without known liver disease and a group of 49 CLD patients, who
were referred for a regular follow-up from the outpatient clinic. The
most common etiology in the patient cohort was chronic hepatitis C
with 33 cases. Clinical and demographic data of the study subjects are
summarized in Table 1.
2.2 | Liver US and SWE
The Samsung RS80A Prestige US scanner (Samsung Medison,
Hongcheon, Korea) equipped with the CA1-7A convex probe was used
for all examinations. All pSWE measurements were performed with the
S-Shearwave v3.0 application, following the manufacturer's rec-
ommended protocol (Figure 1). Briefly, subjects were fasting for at least
4 hours before the examination. The right lobe of the liver was visualized
through an intercostal view. The operator positioned the pSWE mea-
surement box near the centerline of the ultrasound beam, at least 1.5 cm
from the liver capsule but not deeper than 6 cm from the skin surface. LS
measurements were taken during a breath held at mid-inspiration. The
median LS value was reported in m/s. 2D-SWEmeasurements were per-
formed with the S-Shearwave Imaging application in a subset of the
patients. Briefly, a color-coded elastogram of the liver parenchyma was
TABLE 1 Summary of demographic and clinical characteristics of
the healthy control and patient groups
Controls, n = 10 Patients, n = 49
Sex
Male 5 (50%) 22 (45%)
Female 5 (50%) 27 (55%)
Agea 34 (26-43) 62 (58-67)
BMIa 22.9 (22-29) 25.5 (23-28)
Etiology
Chronic hepatitis C N/A 34 (69%)
Chronic hepatitis B N/A 2 (4%)
PSC-PBC N/A 3 (6%)
NASH N/A 2 (4%)
Hemochromatosis N/A 1 (2%)
Alcoholic liver disease N/A 2 (4%)
Unknown etiology N/A 5 (10%)
Fibrosis gradeb
≤F1 N/A 10 (20%)
F2 N/A 8 (16%)
F3 N/A 9 (18%)
F4 N/A 22 (45%)
Abbreviations: BMI, body mass index; N/A, nonapplicable; NASH,
nonalcoholic steatohepatitis; PSC-PBC, primary sclerosing cholangitis—
primary biliary cirrhosis; and TE, transient elastography.
aAge (in years) and BMI (in kg/m2) values are presented as the median and
the interquartile range.
bFibrosis grade was determined with TE as the reference, with cut-off
values as follows: F2 ≥ 7.1 kPa; F3 ≥ 9.5 kPa; F4 ≥ 12.5 kPa8.
F IGURE 1 RMI is used to select reproducible liver stiffness
measurements during S-Shearwave elastography. During pSWE, the
measurement box is freely positioned by the operator on the B-mode
grayscale image; only stiffness values with a good reliable measure index
(RMI ≥0.4) are considered reliable. pSWE, point shearwave elastography;
RMI, reliablemeasure index
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obtained with a convex probe, and the average LS was recorded in circu-
lar ROIs, which were approximately 1 cm in diameter (Figure 2). The ROI
was positioned where the reliable measure index (RMI) was the highest
based on a color-codedmap (Figure 3).
2.3 | Definition of technical success and reliable
measurement
From each subject, at least 10 LS data were collected during pSWE. The
RMI was automatically assigned by S-Shearwave to all measurements on
a scale from 0.0 to 1.0, with 0.1 increments. Based on themanufacturer's
recommendation, only data points with RMI values ≥0.4 were consid-
ered reproducible. Measurements were only technically successful if at
least five valid data points could be collected. The interquartile range
(IQR) of the valid data points also should remain less than 30% of the
median (med.), and measurements with IQR/med. ≥30% were consid-
ered unreliable.
2.4 | Interobserver comparison
In all subjects, pSWE was performed by two different observers on the
same occasion. In 18 subjects, a 2D-SWE measurement of the LS was
also performed by one of the examiners. The observers were blinded to
each other's measurements and the patient's prior TE results.
2.5 | Statistical analysis
The statistical analysis was completed with the R x64 v3.4.1 statistical
package (www.r-project.org). The limit of statistical significance was
set at P < .05. The intraclass correlation coefficient (ICC) was calcu-
lated for LS values, and the Cohen's kappa statistic was calculated for
agreement on the stages of liver fibrosis (METAVIR F0-F4), where
prior TE results were used as a reference. Good interobserver agree-
ment was assumed in these tests when coefficient values were ≥0.75.
Diagnostic performance and cut-off LS values of significant liver fibro-
sis were calculated from measurements from both observers using
receiver operating characteristic (ROC) curve analysis.7
3 | RESULTS
3.1 | Comparison of the control and patient groups
The multivariate analysis of variance test was used to compare demo-
graphic and physiologic variables between the control and patient groups.
There was no significant difference in average weight (78 kg, 95% confi-
dence interval [CI]: 72-83 vs 69 kg, 95% CI: 59-80) or height (168 cm,
95% CI: 164-171 vs 173 cm, 95% CI: 163-183) between patients and
control subjects, respectively. The median age (62 years, interquartile
range: 58-67 vs 34 years, range: 26-43; P < .001) and BMI (25.5 kg/cm2,
range: 23-28 vs 22.9 kg/cm2, range: 21.9-24; P < .05) were both signifi-
cantly higher in the patient group (Table 1). A multiple linear regression
analysis of the demographic variables found that the BMI (β = .07, 95%
CI: 0.04-0.09, P < .001) and the measurements' depth (β = .25, 95% CI:
0.08-0.41, P < .01) are significant positive predictors of LS (R2 = 0.33,
F[2, 85] = 19.56, P < .001). Two of the enrolled subjects had ascites on
US imaging. In two patients, a circumscribed lesion was detected in the
liver, and a follow-up imaging study confirmed the diagnosis of HCC.
3.2 | Technical success rate and reliability of
S-Shearwave measurements
The overall technical success rate with pSWE was 95% (112/118),
considering all cases evaluated by the two examiners. In 4 patients
F IGURE 2 Example on a 2D-SWE measurement with the
S-Shearwave imaging application. A color-coded map of liver elasticity
is obtained, and the average stiffness value is measured in the circular
region of interest selected by the operator. 2D-SWE, two-dimensional
shearwave elastography
F IGURE 3 A color-coded map of the RMI is used for the ROI
selection during 2D-SWE. The measurement ROI (as shown in
Figure 2) is preferably placed by the operator at an area where the
signal-to-noise ratio is the highest (red color) according to the RMI
map. 2D-SWE, two-dimensional shearwave elastography; RMI,
reliable measure index; ROI, region of interest
KAPOSI ET AL. 3
(6.7%, 4/59), either one (2/59) or both examiners (2/59) failed to col-
lect at least five valid data points; these were excluded from further
analysis (Table 2). In 2 cases, the cause of the technical failure was the
patient's low tolerance of breath holds. The BMI was ≥30 in 3 out of
4 failed cases compared with 6 among the remaining subjects with
successful measurements (χ2 = 11.8, P < .05). The 2D-SWE was tech-
nically successful in all 16 examined patients.
The two examiners achieved a success rate of 80% (1104/1379)
in collecting reliable (RMI ≥0.4) data points from the 59 subjects. The
square of measurement depth from the skin surface (β = −.076 95%
CI: −0.14–0.014) was a significant predictor of low RMI in a quadratic
regression model (R2 = 0.43, (F[2, 81] = 30.58, P < .001) (Figure 4).
3.3 | Validation of interobserver reliability and
inter-method reproducibility
Both observers recorded significantly (P < .001) increased median LS in
the patients (observer 1:1.9 m/s, IQR: 1.56-2.26 m/s; observer 2:
1.96 m/s, IQR: 1.54-2.37 m/s) compared to healthy controls (observer
1: 1.29 m/s, range: 1.27-1.37 m/s; observer 2: 1.36 m/s, range:
1.25-1.42 m/s).
The Bland-Altman plot did not indicate significant measurement
bias (Figure 5). A Cohen's kappa analysis (kappa = 0.76; 95% CI:
0.67-0.85, P < .001) showed good reproducibility of the fibrosis grade
as well. The ICC test found excellent agreement between LS values
measured by the two examiners (ICC = 0.92, 95% CI: 0.86-0.95,
P < .001). We also found excellent agreement between pSWE and 2D-
SWE values as measured by one of the observers (ICC = 0.91, 95% CI:
0.79-0.94, P < .001) in 18 subjects.
After the LS values from pSWE were transformed into kPa units,
pSWE was directly compared with TE. Good to excellent reproducibil-
ity was found between the methods when the results from the two
observers were compared separately (ICC = 0.91, 95% CI: 0.84-0.95,
P < .001 or ICC = 0.79, 95% CI: 0.65-0.87, P < .001) (Figure 6). A high
degree of co-linearity was also found with TE in the case of both the
first (rho = 0.91, 95% CI: 0.82-0.95, P < .001) and the second exam-
iner (rho = 0.8, 95% CI: 0.68-0.88, P < .001) (Figure 7).
3.4 | Staging of HCV-associated liver fibrosis and
cut-off LS values
The pSWE measurements from 33 patients with chronic HCV hepati-
tis and the control group were pooled together to create a prediction
set of 86 LS values. The grading of liver fibrosis was based on previ-
ous TE with cut-offs at F2 ≥ 7.1 kPa, F3 ≥ 9.5 kPa, and F4 ≥ 12.5 kPa,
TABLE 2 Interobserver comparison of liver stiffness, technical
success rate, and diagnostic performance for S-Shearwave
measurements
Observer 1 Observer 2 Significance*
Measurement depth
(in cm)a
Controls 4.19 ± 0.51 3.92 ± 0.49 P = .24
Patients 4.54 ± 0.74 4.61 ± 0.7 P = .65
LS (in m/s)a
Controls 1.33 ± 0.12 1.34 ± 0.12 P = .75
Patients 2.02 ± 0.60 2.01 ± 0.61 P = .90
Technical success
rate
95% (56/59) 95% (56/59) N/A
Reliable
measurementsb
98% (58/59) 88% (52/59) P = .03
IQR/med. 12.9% ± 0.06% 17.4% ± 0.11% P = .007
AUROC for ≥F2
fibrosisc
0.97(0.92-1) 0.94 (0.86-1) P = .1
Cut-offd 1.5 1.45 N/A
Sensitivity 96.3% 88.9% N/A
Specificity 93.8% 81.2% N/A
PPV 95.5% 88.9% N/A
NPV 96.3% 81.3% N/A
Abbreviations: AUROC, area under receiver operating characteristic curve;
CI, confidence interval; IQR, interquartile range; LS, liver stiffness; med.,
median; N/A, nonapplicable; NPV, negative predictive value; PPV, positive
predictive value.
*Cut-off for statistical significance at P < .05.
aThe depth of measurement and LS are shown as mean ± SD.
bIQR/med. ≤30%.
cROC curve calculated for ≥F2 grade HCV-related fibrosis, AUROC, and
95% CI.
dCut-off value (m/s).
F IGURE 4 The ratio of reliable to all LS measurements shows an
inverse relationship with the depth of the measurement. A
downward-sloping quadratic regression line can be fitted on the
scatter plot, which indicates an exponential decrease in the ratio of
reliable measurement by increasing the depth of the measurement
box from the skin surface. The dashed lines represent the 95% CI. CI,
confidence interval; LS, liver stiffness
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respectively.8 The distribution of LS values measured by pSWE was
significantly different between the METAVIR categories in all compar-
isons (P < .05) (Figure 8).
The ROC analysis showed a good classification rate between cases
with nonsignificant grade (F0 and F1) and moderate fibrosis (F2) with
area under the ROC curve (AUROC = 0.72, 95% CI: 0.5-0.94, P < .001)
F IGURE 5 Analysis of the interobserver agreement with
S-Shearwave elastography. A Bland-Altman plot shows that there is
no systemic bias between pSWE measurements of the two
independent observers. The mean of LS differences (dash-dotted line)
was not significantly different from the baseline (solid line). Dashed
lines represent upper and lower limits of 95% interobserver
agreement. LS, liver stiffness; pSWE, point shearwave elastography
F IGURE 6 A good intermethod agreement is found between
S-Shearwave and transient elastography. The Bland-Altman plot shows
good agreement between the measurements of both observers and the
TE results. Notably, the disagreement between the methods is
relatively greater in the low LS range. The stiffness values from pSWE
were converted to kPa units before the comparison. LS, liver stiffness;
pSWE, point shearwave elastography; TE, transient elastography
F IGURE 7 S-Shearwave measurements show very good
correlation with transient elastography. A high degree of positive
linear correlation was found between pSWE and TE (Spearman's
rho = 0.85). The solid lines represent the predicted TE values for each
observer, while the gray-shaded margins correspond to 95%
confidence intervals (CI). CI, confidence interval; pSWE, point
shearwave elastography; TE, transient elastography
F IGURE 8 Staging of HCV-associated liver fibrosis with
S-Shearwave elastography. The boxplots show the range of stiffness
values measured with pSWE in the consecutive stages of liver
fibrosis. The solid line inside the box represents the median; the
whiskers represent the 150% outliers of the interquartile range. HCV,
hepatitis C virus; pSWE, point shearwave elastography
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being significantly different from the line of no discrimination (Figure 9).
The correct classification rate was even better for moderate (F2) vs
severe fibrosis (AUROC = 0.96, 95% CI: 0.86-1, P < .001) and between
severe fibrosis (F3) and cirrhosis (F4; AUROC = 0.89, 95% CI: 0.76-1,
P < .001). In a three-way ROC analysis, the subjects were divided into
three classes (no-significant fibrosis [F0 or F1], significant fibrosis [F2 or
F3], and cirrhosis) and the volume under the surface (VUS = 0.82, 95%
CI: 0.71-0.93, P < .001) indicated a very good diagnostic performance.
The cut-off LS values with the highest Youden index were also calcu-
lated for ≥F2 (1.46 m/s; specificity (sp) = 84%; sensitivity (se) = 62%;
negative predictive value (npv) = 90%; positive predictive value
(ppv) = 50%), ≥F3 (1.63 m/s; sp = 100%; se = 93%; npv = 89%;
ppv = 100%), and F4 (1.95 m/s; sp = 81%; se = 90%; npv = 81%;
ppv = 90%) grade liver fibrosis.
Both observers achieved excellent prediction rate of ≥F2 liver
fibrosis (AUROC = 0.97, 0.92-1 vs 0.94 95% CI: 0.86-1), while com-
parison of the ROC curves did not find a significant difference
(P = 0.1). The cut-off LS value for the first observer was nearly identi-
cal to that of the second observer (1.5 m/s vs 1.45 m/s) (Table 2). The
post hoc power calculation indicated that F0-F1 vs F2 classification
had greater than 20% type II error rate, otherwise the size of the
cohort was sufficient to achieve a minimum of 80% power in all of the
ROC classifications.
4 | DISCUSSION
Morphological imaging techniques, such as B-mode US and computed
tomography, have low sensitivity for diagnosing liver fibrosis. These
modalities can only diagnose the cirrhotic stage when overt signs of
architectural distortion and portal hypertension are present.9 Other
methods such as magnetic resonance elastography are only applicable
to preselected patient groups.10
According to recent guidelines, noninvasive markers including
elastography are recommended for the initial assessment of liver
fibrosis in both HBV- and HCV-associated liver diseases, while a liver
biopsy is only preferred in selected cases, where there is uncertainty
or potential additional etiologies.4,11 SWE, including pSWE and 2D-
SWE, are relatively new techniques, which can be performed on any
patient during a routine liver US examination.12 In our opinion, SWE
arguably has the potential to become a universally accepted method
for the assessment and follow-up of liver fibrosis.
Therefore, SWE can be easily integrated into HCC surveillance
protocols. Notably, in two cases, a tumor was also found during the
elastography scan, while in an additional case the LS measurement
was successful even in the presence of a significant amount of ascites.
Although the operating principle is similar for all SWE systems, the
diagnostic accuracy and cut-off values may be different based on the
manufacturer.13 Considering the potentially large number of operators,
validation of these applications is essential to maintain diagnostic perfor-
mance. There was no technically failed measurements in the control
group, which highlights the straightforward operation of S-Shearwave.
In agreement with current guidelines, we acquired at least 10 data
points in each subject.3 Each of the data points was tagged with a signal-
to-noise indicator RMI. This is calculated from the wave equation resid-
uals and shear wave magnitude by the S-Shearwave application.14 The
decreased signal-to-noise ratio results in low RMI reading. In our experi-
ence, RMI has been useful to identify a subset of cases where pSWE is
technically challenging, and additional data points need to be collected
for reliable measurement. The cause of technical failure in two cases was
that elderly patients did not tolerate breath holds. Previous studies have
found similar technical success rate with other pSWE scanners.15,16
A prior study reported one failed (3%) and two unreliable measurements
(6%) in 33 subjects examined with S-Shearwave.6 The authors also
claimed that obesity was the primary cause of technical failure in these
cases. The BMI was >30 in nine of our patients; among them three had
failed pSWEmeasurements. Measurement depth also proved to be a sig-
nificant negative predictor of low RMI reading and technical failure in a
linear quadratic model. Thus, we have demonstrated in vivo that the reli-
ability of LS measurements exponentially decreases with increasing dis-
tance of ROI from the skin surface. These findings are also in agreement
with phantom studies, which demonstrated higher coefficient variations
with increasing probe-to-ROI distance.17
The intra- and interobserver reproducibility values of various pSWE
scanners have been extensively validated in previous studies.6,15We found
excellent interobserver agreement (ICC=0.92),which surpassedother plat-
forms tested on healthy subjects (ICC = 0.86) or liver patients (ICC = 0.84
F IGURE 9 ROC analysis of the diagnostic accuracy of S-Shearwave
measurements. The ROC curves show the diagnostic performance of
pSWE for increasing grades of liver fibrosis (solid, dashed, and long-
dashed lines) in chronic hepatitis C virus infection. The accuracy of the
method is better for higher grades of fibrosis as indicated by the AUC of
the curves. The dotsmark the optimal cut-off valuewith the highest
Youden index on each curve, andwhiskers represent the 95%CI of the
curve. AUC, area under the ROC curve; pSWE, point shearwave
elastography; ROC, receiver operating characteristic
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and ICC = 0.798).18,19 One previous publication has also reported an excel-
lent interobserver agreement (ICC > 0.9) in a smaller patient groupwith the
S-Shearwave application.6 The intermethod agreement between pSWE
and 2D-SWE (ICC = 0.91) was also excellent, although the relatively low
number of subjects limits the power of the analysis.
TE is accepted as a surrogate of liver biopsy for the diagnosis of
liver fibrosis according to the international guidelines on the diagnosis
and treatment of chronic hepatitis.1-3 Therefore it is quite reassuring
that S-Shearwave elastography showed a high degree of correlation
(rho = 0.85) and very good agreement on LS values (ICC = 0.86) with
TE measurements.
In our study, S-Shearwave demonstrated excellent diagnostic
accuracy in the detection of clinically significant (≥F2 grade) liver
fibrosis in the hands of both operators. The high AUROC values of
0.94 and 0.97 are well comparable to other reports assessing pSWE.
S-Shearwave also showed very good performance in the detection of
liver cirrhosis (AUROC 0.89). The three-way ROC analysis performs
simultaneous detection and classification of the cases.20 pSWE
achieved a very good classification rate (VUS = 0.82) when nonsignifi-
cant fibrosis, fibrosis, and cirrhosis were simultaneously compared in a
multiclass decision model. These findings suggest that S-Shearwave
can be an excellent tool for screening of liver fibrosis. A post hoc
power calculation was performed and it showed that our cohort size
was sufficient to achieve a less than 0.2 type II error rate in all of the
classification steps with one exception. The ROC analysis was under-
powered only for the F0-1 vs F2 prediction. In our opinion, it does not
change the basic interpretation of our findings as cases with signifi-
cant fibrosis (≥F2) could be classified by both observers with a mini-
mum power of 80%. Moreover, all of the ROC curves were also
statistically significant (P < .05).
Our study has several limitations. Firstly, fibrosis grade in the patient
group was estimated by TE, and liver biopsy was not available for
comparison with pSWE. Our study design is still sound, as TE is a well-
established surrogate of liver biopsy for grading fibrosis according to
current clinical protocols. Patients could also be spared from unneces-
sary risk of complication from a liver biopsy. Secondly, the number of
subjects was relatively small compared to larger multicenter studies.
Also, high grades of fibrosis (F3 and F4) were overrepresented among
the patients. Therefore, investigation of larger cohorts of patients with a
more uniform clinical background is necessary to formulate comprehen-
sive diagnostic recommendations for S-Shearwave.
In conclusion, S-Shearwave elastography utilizes a user-friendly
quality index the RMI for the selection of reliable LS measurements.
Both interobserver agreement intermethod reproducibility was excel-
lent with S-Shearwave, and the method showed very good overall
performance in the staging of liver fibrosis.
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